对心脏性休克患者基于生物标志物的死亡率评分的验证:与临床风险评分的比较
Elina Hynninen1, Heli Tolppanen1, Mercedes Rivas-Lasarte2
1Department of Cardiology, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
ESC heart failure
|February 3, 2025
概括
在入院12小时内,CLIP得分准确地预测心脏性休克 (CS) 患者的90天死亡率. 这种基于生物标志物的评分补充了现有的风险评分,有助于临床决策和急性心力衰竭的试验设计.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 生物标志物发现发现
背景情况:
- 心脏性休克 (CS) 是一种严重的急性心力衰竭形式,死亡率高.
- 准确的风险预测对于管理CS患者和设计临床试验至关重要.
- 现有的风险评分可能需要增强,以提高预后准确度.
研究的目的:
- 为了验证CLIP得分 (cystatin C,乳酸盐,互白素-6,NT-proBNP) 以预测急性冠状动脉综合征 (ACS) 相关的90天死亡率.
- 将CLIP评分的预测性能与已建立的CardShock风险评分进行比较.
- 评估CLIP得分在风险分层和临床决策中的有用性.
主要方法:
- 对前性,观察性欧洲卡片冲击研究队伍的后期分析 (n=121).
- 在入院12小时内计算的CLIP得分.
- 用于评估预测准确性 (AUC) 和比较分数的接收器运行特征 (ROC) 曲线分析.
主要成果:
- 该CLIP得分显示,90天死亡率的预测准确度很高 (AUC为0.84).
- CLIP评分的预测值与CardShock风险评分 (AUC 0.77) 的预测值相当.
- 0.28的CLIP分数切断线有效地将患者分为高风险 (65%的死亡率) 和低风险 (16%的死亡率) 的两组.
- 将CLIP得分纳入所有CardShock风险得分类别的风险分层进行了改进.
结论:
- 在入院后早期计算时,CLIP得分准确地预测了CS患者的90天死亡率.
- CLIP评分是CardShock风险评分的宝贵补充,增强了预后评估.
- 这种基于生物标志物的评分具有动态风险评估的潜力,指导临床管理和CS的未来试验设计.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
86
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
86
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
43
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
43
01:24Blood Pressure Imbalances and Circulatory Shock
740
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
740